FA
LLY icon

Faithward Advisors’s Eli Lilly LLY Stock Holding History

Faithward Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Sell
862
-134
-13% -$137K 0.13% 143
2026
Q1 		$916K Buy
996
+95
+11% +$96.3K 0.13% 135
2025
Q4 		$968K Buy
901
+613
+213% +$586K 0.14% 130
2025
Q3 		$220K Sell
288
-75
-21% -$55.8K 0.03% 287
2025
Q2 		$283K Buy
+363
New +$282K 0.04% 224
2024
Q4 		– Sell
-643
Closed -$570K – 280
2024
Q3 		$570K Buy
643
+31
+5% +$27.9K 0.1% 153
2024
Q2 		$554K Sell
612
-13
-2% -$10.4K 0.1% 152
2024
Q1 		$486K Buy
+625
New +$445K 0.09% 158

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Faithward Advisors's LLY Position: Q2 2026 in Review

Faithward Advisors reduced its Eli Lilly (LLY) stake by 13% in Q2 2026, selling an estimated $137K and leaving 862 shares worth $1.03M. The position accounts for 0.13% of the portfolio, ranked #143.

Faithward Advisors first reported a position in LLY in Q1 2024 and has held it in 8 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Faithward Advisors held 862 shares of Eli Lilly worth $1.03M as of Q2 2026.
  • Faithward Advisors sold 134 Eli Lilly shares in Q2 2026, an estimated $137K.
  • Eli Lilly made up 0.13% of Faithward Advisors's portfolio in Q2 2026, its #143 holding.
  • Faithward Advisors first reported a position in Eli Lilly in Q1 2024 and has held it in 8 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Faithward Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.